Pharmacology of pannexin channels.

[1]  Carlos Augusto Real Martinez,et al.  The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders , 2022, International journal of molecular sciences.

[2]  J. Contreras,et al.  Mechanisms of ATP release in pain: role of pannexin and connexin channels , 2021, Purinergic Signalling.

[3]  W. Kuebler,et al.  Pannexin 1-a novel regulator of acute hypoxic pulmonary vasoconstriction. , 2021, Cardiovascular research.

[4]  Samy Lamouille,et al.  Mechanisms of Connexin Regulating Peptides , 2021, International journal of molecular sciences.

[5]  D. Laird,et al.  Pannexin biology and emerging linkages to cancer. , 2021, Trends in cancer.

[6]  B. Isakson,et al.  Pannexin 1 as a driver of inflammation and ischemia–reperfusion injury , 2021, Purinergic Signalling.

[7]  J. Siegel,et al.  Discovery of a natural cyan blue: A unique food-sourced anthocyanin could replace synthetic brilliant blue , 2021, Science Advances.

[8]  Michael Koval,et al.  A venous-specific purinergic signaling cascade initiated by Pannexin 1 regulates TNFα-induced increases in endothelial permeability , 2021, Science Signaling.

[9]  A. M. Kozlov,et al.  Pannexin 1 binds β-catenin to modulate melanoma cell growth and metabolism , 2021, The Journal of biological chemistry.

[10]  Christine E Shulenberger,et al.  Nonsteroidal Mineralocorticoid Receptor Antagonists: Exploring Role in Cardiovascular Disease , 2021, Journal of cardiovascular pharmacology.

[11]  M. Yeager,et al.  ATP and large signaling metabolites flux through caspase-activated Pannexin 1 channels , 2021, eLife.

[12]  Li-Chen Chen,et al.  Blocking pannexin1 reduces airway inflammation in a murine model of asthma. , 2020 .

[13]  Roger J. Thompson,et al.  PANNEXIN 1 CHANNELS AS A THERAPEUTIC TARGET: STRUCTURE, INHIBITION, AND OUTLOOK. , 2020, ACS chemical neuroscience.

[14]  Z. Ruan,et al.  Structures of human pannexin 1 reveal ion pathways and mechanism of gating , 2020, Nature.

[15]  D. Bayliss,et al.  PANNEXIN 1 CHANNELS IN RENIN-EXPRESSING CELLS INFLUENCE RENIN SECRETION AND BLOOD PRESSURE HOMEOSTASIS. , 2020, Kidney international.

[16]  C. Naus,et al.  Glial connexins and pannexins in the healthy and diseased brain. , 2020, Physiological reviews.

[17]  T. Kawate,et al.  The Cryo-EM structure of pannexin 1 reveals unique motifs for ion selection and inhibition , 2020, eLife.

[18]  F. Ezquer,et al.  Contribution of Connexin Hemichannels to the Decreases in Cell Viability Induced by Linoleic Acid in the Human Lens Epithelial Cells (HLE-B3) , 2020, Frontiers in Physiology.

[19]  Ashley M. Miller,et al.  Endothelial Pannexin 1 Channels Control Inflammation by Regulating Intracellular Calcium , 2019, The Journal of Immunology.

[20]  J. Gilthorpe,et al.  Role of pannexin-1 in the cellular uptake, release and hydrolysis of anandamide by T84 colon cancer cells , 2019, Scientific Reports.

[21]  Roger J. Thompson,et al.  Constitutive SRC-mediated phosphorylation of pannexin 1 at tyrosine 198 occurs at the plasma membrane , 2019, The Journal of Biological Chemistry.

[22]  A. Gunn,et al.  The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation , 2019, Front. Physiol..

[23]  D. Bayliss,et al.  Pannexin-1 channels on endothelial cells mediate vascular inflammation during lung ischemia-reperfusion injury. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[24]  B. Kwak,et al.  Connexins and Pannexins in Vascular Function and Disease , 2018, International journal of molecular sciences.

[25]  L. Capelle,et al.  Pannexin-1 channels contribute to seizure generation in human epileptic brain tissue and in a mouse model of epilepsy , 2018, Science Translational Medicine.

[26]  D. Bayliss,et al.  Revisiting multimodal activation and channel properties of Pannexin 1 , 2018, The Journal of general physiology.

[27]  D. Bayliss,et al.  Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone , 2017, Circulation research.

[28]  I. Rustenbeck,et al.  The inhibitor of connexin Cx36 channels, mefloquine, inhibits voltage-dependent Ca2+ channels and insulin secretion , 2017, Molecular and Cellular Endocrinology.

[29]  Roger J. Thompson,et al.  Regulation of pannexin channels in the central nervous system by Src family kinases , 2017, Neuroscience Letters.

[30]  M. Yeager,et al.  A quantized mechanism for activation of pannexin channels , 2017, Nature Communications.

[31]  Michael Mousseau,et al.  Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents , 2017, Nature Medicine.

[32]  D. Laird,et al.  Next-Generation Connexin and Pannexin Cell Biology. , 2016, Trends in cell biology.

[33]  Roger J. Thompson,et al.  Metabotropic NMDA receptor signaling couples Src family kinases to pannexin-1 during excitotoxicity , 2016, Nature Neuroscience.

[34]  T. Kawate,et al.  Carbenoxolone inhibits Pannexin1 channels through interactions in the first extracellular loop , 2016, The Journal of general physiology.

[35]  K. Stokes,et al.  Pannexin 1 channels regulate leukocyte emigration through the venous endothelium during acute inflammation , 2015, Nature Communications.

[36]  N. Dale,et al.  Pannexin-1-mediated ATP release from area CA3 drives mGlu5-dependent neuronal oscillations , 2015, Neuropharmacology.

[37]  M. Billaud,et al.  Emerging concepts regarding pannexin 1 in the vasculature. , 2015, Biochemical Society transactions.

[38]  Roger J. Thompson,et al.  A molecular signature in the pannexin1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells , 2015, Science Signaling.

[39]  Johannes P. Hofgaard,et al.  Activation, Permeability, and Inhibition of Astrocytic and Neuronal Large Pore (Hemi)channels*♦ , 2014, The Journal of Biological Chemistry.

[40]  D. Laird,et al.  Pannexin channels and their links to human disease. , 2014, The Biochemical journal.

[41]  J. Sleigh,et al.  Investigation into the role of gap junction modulation of intracortical connectivity in mouse neocortical brain slices , 2014, Brain Research.

[42]  D. Bayliss,et al.  Unexpected link between an antibiotic, pannexin channels, and apoptosis , 2014, Nature.

[43]  H. Aguila,et al.  Pannexin1 channels act downstream of P2X7 receptors in ATP-induced murine T-cell death , 2014, Channels.

[44]  Roger J. Thompson,et al.  Pannexin-1 as a potentiator of ligand-gated receptor signaling , 2014, Channels.

[45]  Stephen R. Bond,et al.  The pannexins: past and present , 2014, Front. Physiol..

[46]  G. Dahl,et al.  The bizarre pharmacology of the ATP release channel pannexin1 , 2013, Neuropharmacology.

[47]  E. Scemes,et al.  Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model , 2013, Scientific Reports.

[48]  G. Dahl,et al.  The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1 , 2013, The Journal of general physiology.

[49]  M. F. Bystrova,et al.  The ATP permeability of pannexin 1 channels in a heterologous system and in mammalian taste cells is dispensable , 2012, Journal of Cell Science.

[50]  C. Rose,et al.  Thrombin-induced ATP release from human umbilical vein endothelial cells. , 2012, American journal of physiology. Cell physiology.

[51]  Jeffrey R. Morgan,et al.  Pannexin1 Drives Multicellular Aggregate Compaction via a Signaling Cascade That Remodels the Actin Cytoskeleton* , 2012, The Journal of Biological Chemistry.

[52]  J. Velíšková,et al.  Targeting Pannexin1 Improves Seizure Outcome , 2011, PloS one.

[53]  E. Kobatake,et al.  Homeostasis of Extracellular ATP in Human Erythrocytes* , 2011, The Journal of Biological Chemistry.

[54]  P. Ganey,et al.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[55]  Alexander Hillisch,et al.  A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule* , 2010, The Journal of Biological Chemistry.

[56]  D. Spray,et al.  Mefloquine Blockade of Pannexin1 Currents: Resolution of a Conflict , 2010, Cell communication & adhesion.

[57]  A. Surprenant,et al.  Pharmacological Characterization of Pannexin-1 Currents Expressed in Mammalian Cells , 2009, Journal of Pharmacology and Experimental Therapeutics.

[58]  G. Dahl,et al.  A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. , 2009, American journal of physiology. Cell physiology.

[59]  Roger J. Thompson,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 References Activation of Pannexin-1 Hemichannels Augments Aberrant Bursting in the Hippocampus , 2022 .

[60]  D. Spray,et al.  P2X7 receptor-Pannexin1 complex: pharmacology and signaling. , 2008, American journal of physiology. Cell physiology.

[61]  G. Dahl,et al.  Probenecid, a gout remedy, inhibits pannexin 1 channels. , 2008, American journal of physiology. Cell physiology.

[62]  R. W. Keane,et al.  Modulation of membrane channel currents by gap junction protein mimetic peptides: size matters. , 2007, American journal of physiology. Cell physiology.

[63]  N. Chaudhari,et al.  The role of pannexin 1 hemichannels in ATP release and cell–cell communication in mouse taste buds , 2007, Proceedings of the National Academy of Sciences.

[64]  A. Surprenant,et al.  Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor , 2006, The EMBO journal.

[65]  H. Monyer,et al.  Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes , 2005, Journal of neurochemistry.

[66]  B. Connors,et al.  Potent block of Cx36 and Cx50 gap junction channels by mefloquine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[67]  L. Gerena,et al.  The Antimalarial Potential of 4-Quinolinecarbinolamines May Be Limited due to Neurotoxicity and Cross-Resistance in Mefloquine-Resistant Plasmodium falciparum Strains , 2004, Antimicrobial Agents and Chemotherapy.

[68]  S. Boitano,et al.  Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication. , 2001, Biochemical Society transactions.

[69]  R. Stone,et al.  A release mechanism for stored ATP in ocular ciliary epithelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[70]  E. Harley,et al.  Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. , 1986, Biochemical and biophysical research communications.

[71]  P. Dayton,et al.  Clinical Pharmacokinetics of Probenecid , 1981, Clinical pharmacokinetics.

[72]  K. Rieckmann,et al.  Mefloquine (WR 142,490) in the treatment of human malaria , 1975, Science.

[73]  T. H. Steele.  Control of uric acid excretion. , 1971, The New England journal of medicine.

[74]  M. Nyberg,et al.  Probenecid Inhibits &agr;-Adrenergic Receptor–Mediated Vasoconstriction in the Human Leg Vasculature , 2018, Hypertension.